<DOC>
	<DOCNO>NCT00293904</DOCNO>
	<brief_summary>The purpose study evaluate whether use specific immunomodulatory principle ( QbG10 ) together conventional grass pollen allergen lead rapid pronounced decrease sensitivity pollen grass pollen allergen alone</brief_summary>
	<brief_title>Safety Efficacy Allergen Vaccine Grass-Pollen Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>18 65 year age Mild moderate seasonal allergic rhinoconjunctivitis due sensitization grass pollen evident history ( ≥ 2 year ) , positive nasal provocation test ( NPT ) positive skin prick test ( SPT , wheal ≥ 3mm large diluent ) grass pollen extract Female participant must meet one follow criterion : No reproductive potential due menopause ( one year without menses , case doubt serum FSH determine must &gt; 40 U/mL ) , hysterectomy , bilateral oophorectomy , tubal ligation . Patient agree consistently practice effective accept method contraception throughout duration study 1 additional month last immunization ( hormonebased , intrauterine device , double barrier contraception , i.e . condom + diaphragm , condom diaphragm + spermicidal gel foam ) Written informed consent Patient willing able comply trial requirement Additional allergy ( seasonal perennial ) symptoms overlap temporally screen treatment period Contraindication Allergen Preparation Contraindication Nasal Provocation Test Contraindication Skin Prick Test Actual significant obstructive pulmonary disorder ( FEV1 &lt; 70 % ) Pharmacological treatment could affect allergic sensitivity trial Presence history significant cardiovascular , renal , pulmonary , endocrine , autoimmune , neurological , psychiatric disease judge investigator Serum test positive HIV , HBV , HCV Current diagnosis history malignancy ; presence suspicious lymphadenopathy splenomegaly physical examination Pregnancy lactation Blood donation within 30 day enrolment History abuse alcohol recreational drug Specific immunotherapy pollen allergy within last two year Intake investigational drug within three month enrolment Intake contraindicate medicament SIT Betablockers , ACE/ATII Inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Grass Pollen</keyword>
	<keyword>Systemic Immunotherapy</keyword>
</DOC>